ACGN
Aceragen, Inc.

48
Loading...
Loading...
Aceragen, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of medications for rare and orphan diseases. The firm's product portfolio includes ACG-801 and ACG-701, which targets Farber Disease, Melioidosis, and Cystic Fibrosis. The company was founded in 1989 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Aceragen Inc?
What is the 52-week high for Aceragen Inc?
What is the 52-week low for Aceragen Inc?
What is Aceragen Inc stock price today?
What was Aceragen Inc stock price yesterday?
What is the PE ratio of Aceragen Inc?
What is the Price-to-Book ratio of Aceragen Inc?
What is the 50-day moving average of Aceragen Inc?

Latest ACGN News

View
No ACGN news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.